Alzamend Neuro Inc (ALZN)
0.6298
0.00 (0.00%)
USD |
NASDAQ |
May 21, 16:00
0.62
-0.01
(-1.56%)
After-Hours: 20:00
Alzamend Neuro Shareholders Equity (Quarterly): -4.264M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -4.264M |
| October 31, 2023 | -2.682M |
| July 31, 2023 | -0.1129M |
| April 30, 2023 | 3.046M |
| January 31, 2023 | 5.860M |
| October 31, 2022 | 8.787M |
| July 31, 2022 | 11.18M |
| Date | Value |
|---|---|
| April 30, 2022 | 13.35M |
| January 31, 2022 | 11.96M |
| October 31, 2021 | 13.03M |
| July 31, 2021 | 15.34M |
| April 30, 2021 | 2.013M |
| January 31, 2021 | -1.296M |
| April 30, 2020 | 0.8217M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.264M
Minimum
Jan 2024
15.34M
Maximum
Jul 2021
5.503M
Average
4.452M
Median
Shareholders Equity (Quarterly) Benchmarks
| Retractable Technologies Inc | 99.66M |
| BioCardia Inc | -2.275M |
| Summit Therapeutics Inc | 44.21M |
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.7826M |
| Total Liabilities (Quarterly) | 5.046M |